A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.

Why are some filings missing?

New filings appear as the SEC updates EDGAR, and older records can vary by availability.

How often is this page updated?

Updates follow new EDGAR submissions and periodic data refreshes.

SEC EDGAR filings, ownership reports, and insider transactions for Mark E. Bunnage.

Business address: C/O Vertex Pharmaceuticals Incorporated, 50 Northern Avenue, Boston, MA, 02210
Top holdings (ownership): VRTX

Get insider transactions for this reporting owner

Mark E. Bunnage has filed 8 SEC EDGAR filings since 03 Feb 2026

Recent SEC filings for Mark E. Bunnage including 144, 4, 3.

Form type	Document	Filing	Description	Filing date	Reporting date	File number(s)
144	Open 144 document	View SEC filing for 144		25 Feb 2026
4	Open 4 document	View SEC filing for 4	FORM 4	19 Feb 2026	17 Feb 2026	000-19319
4	Open 4 document	View SEC filing for 4	FORM 4	18 Feb 2026	13 Feb 2026	000-19319
144	Open 144 document	View SEC filing for 144		18 Feb 2026
144	Open 144 document	View SEC filing for 144		17 Feb 2026
4	Open 4 document	View SEC filing for 4	FORM 4	12 Feb 2026	10 Feb 2026	000-19319
144	Open 144 document	View SEC filing for 144		11 Feb 2026
3	Open 3 document	View SEC filing for 3	FORM 3	03 Feb 2026	01 Feb 2026	000-19319

Mark E. Bunnage files with the SEC under CIK 0002100735. This page aggregates EDGAR filings and related ownership activity.

What is a CIK?: A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?: New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?: Updates follow new EDGAR submissions and periodic data refreshes.